Infection & Immunity

Dreaming Big to End A Pandemic

COVID-19: Dreaming Big to End A Pandemic


2020 October

<p><strong></strong>Help Us End the Pandemic.<em></em></p>

Help Us End the Pandemic.

With your help, we are finding answers to COVID-19’s most pressing questions, from testing to transmission to treatments. Together, we can end the pandemic.


Money raised to date

$ 0

$ 7,589,681
$ 4,000,000



The COVID-19 pandemic has taken lives and fundamentally changed our world. MI4 is fighting back to keep our population healthy and safe.

The MUHC Foundation created the COVID-19 Emergency Fund to allow the MUHC and the McGill Interdisciplinary Initiative in Infection and Immunity (MI4) to rapidly launch critical research projects to end this virus and support the tireless efforts of our hospital staff.



For an unprecedented crisis, a comprehensive response.

Even before the COVID-19 pandemic was declared, the McGill Interdisciplinary Initiative in Infection and Immunity (MI4) was mobilizing to begin research into the novel coronavirus. With 250 researchers from a wide range of fields, they are on the forefront of understanding and stopping COVID-19.

  1. Ground-breaking COVID-19 research

    MI4’s expert scientists are studying how the coronavirus transmits, developing new treatments to stop it from taking lives, creating new ways to test for the virus and so much more.

  2. Community support

    COVID-19 is a threat to our lives and livelihoods, especially for our city’s most vulnerable. MI4’s scientists are supporting frontline workers, marginalized communities and incarcerated individuals through education and testing strategies.

  3. Safeguarding well-being

    COVID-19 is not only at threat to our physical health, but our well-being. MI4’s researchers are finding ways to reduce feelings of isolation for patients hospitalized with COVID-19 and safeguard the mental health of frontline health care workers.

"We had 250 researchers who would have been sitting on their hands during the entire first wave if not for the funding from our community."

Dr. Don Sheppard

Founder, MI4


News & Impact

What We've Done So Far

Clinical Trial for COVID-19 Treatment begins after FDA & Health Canada approval

After months of preparation, a global phase III clinical trial sponsored by the Research Institute of the McGill University Health Centre (RI-MUHC), in partnership with Canadian start-up

TELUS helps combat isolation in hospitalized patients

A gift from TELUS CEO Darren Entwistle allowed Dr. Inés Colmegna to study how video calling can alleviate loneliness in hospitalized patients

Help Us End the Pandemic.

Read our Inspiring Stories 

Read Here